|
SIR values(95%CI) in relation to overall cancer incidence and some selected tumour types and laterality and bilaterality at diagnosis of gynecomastia. Included are only prospective cases. |
|||
| Gynecomastia |
|||
|
|
|||
| Unilateral |
Bilateral |
||
| right |
left |
||
| Tumour type |
|||
| all sites |
1.22(0.89–1.71) |
0.90(0.60–1.31) |
0.87(0.35–1.79) |
| testicle |
4.03(0.10–22.97) |
9.26(1.12–33.47) |
0.00(0.00–71.05) |
| esophagus |
6.11(0.74–22.08) |
0.00(0.00–10.22) |
10.33(0.26–57.55) |
| skin cancer (melanoma excl.) |
2.44(0.67–6.29) |
4.18(1.80–8.24) |
1.99(0.05–11.06) |
| number |
196 |
194 |
55 |
| personyears |
3588 |
3910 |
878 |
Olsson et al. BMC Cancer 2002 2:26 doi:10.1186/1471-2407-2-26 |
|||